MZT - nee Matritech - joins Inverness:
This article was originally published in Clinica
Inverness Medical Innovations has completed its acquisition of Newton, Massaschusetts-based cancer diagnostics developer Matritech. On the closing of the transaction, Matritech has changed its name to MZT Holdings and will be shortly seeking a delisting from the American Stock Exchange. Inverness, through its newly-formed subsidiary Milano Acquisitions, purchased all assets of MZT in exchange for 616,671 Inverness. Based on the Waltham, Massachusetts firm's closing price on December 12, this gave the shares a total value of $34.7m.